Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Varicella zoster virus (VZV), also known as human herpesvirus 3 (HHV-3), is a member of the Herpesviridae family and causes two major diseases: varicella (chickenpox) during primary infection and herpes zoster (shingles) upon reactivation from latency. It is a highly contagious, human-restricted DNA virus. After recovery from chickenpox, VZV establishes lifelong latency in sensory nerve ganglia. Reactivation leads to herpes zoster (shingles).
Acyclovir, valacyclovir, and famciclovir are antiviral drugs that inhibit viral DNA polymerase. Varicella vaccine stimulates an immune response to prevent VZV infection.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Varicella zoster virus (None).